Название документа

Darnitsa Bromhexine is a medicine which is applied at cough and catarrhal diseases. For sekretolitichesky therapy at the sharp and chronic bronchopulmonary diseases which are followed by difficulty of an otkhozhdeniye of a phlegm.

Structure

  • 1 tablet contains Bromhexine of a hydrochloride 8 mg;
  • excipients: lactose, potato starch, calcium stearate.

Contraindication

Hypersensitivity to medicine components; peptic ulcer of a stomach and duodenum; diseases of a respiratory system which course is followed by formation of a large number of a liquid phlegm.

Route of administration

Medicine to apply

inside, irrespective of meal. Duration of reception depends on indications and the course of the disease and is established individually.

to Adults and children 14 years on 1-2 tablets (8-16 mg) 3 times a day are more senior than

. A course of treatment - 4-5 days.

to Children aged from 6 up to 14 years and also the patient with body weight less than 50 kg: on 1 tablet (4-8 mg) 3 times a day. A course of treatment - 4-5 days.

Feature of application

With care to use medicament to the patients having bronchial asthma and to patients with a renal or heavy liver failure (i.e. to increase intervals between receptions or to reduce a dose).

In a sharp renal failure needs to consider a possibility of accumulation of metabolites of Bromhexine in a liver.

Pregnant women

appoint medicine by

during pregnancy taking into account a ratio advantage for mother/risk for a fruit.

Children

apply Medicine to children aged from 6 years. To children up to 6 years to apply in other dosage forms.

Drivers

Are not present messages that medicine can affect ability to drive the car or to work with mechanisms.

Overdose

Dispepsichesky frustration, nausea, vomiting, diarrhea, dizziness, headache, diplopia, ataxy, slight metabolic acidosis, Tachypnea. No chronic toxic action on the person is revealed.

Side effects

from nervous system: a headache (as migraine), dizziness.

from the respiratory system, bodies of a thorax and mediastinum: strengthening of cough, bronchospasm, disorders of breath, respiratory distress.

from digestive tract: the dispepsichesky phenomena, nausea, vomiting, diarrhea, an abdominal pain, exacerbation of a peptic ulcer of a stomach and duodenum, tranzitorny increase in activity of aminotransferases in blood serum.

Storage conditions

to Store

in original packing at a temperature not above 25 °C. To store out of children's reach.

Characteristics
Active ingredients Bromhexine
Amount of active ingredient 8 mg
Applicant Darnitsa
Code of automatic telephone exchange R05CB02 Bromhexine
Interaction with food It doesn't matter
Light sensitivity Not sensitive
Market status Generic-generic
Origin Chemical
Prescription status Without prescription
Primary packing planimetric cellular packing
Producer DARNITSA CIAO PHARMACEUTICAL. FIRM
Quantity in packing 50 tablets
Release form tablets for internal use
Route of administration Oral
Sign Domestic
Storage temperature from 5 °C to 25 °C
Trade name Bromhexine

Reviews Bromhexin-Darnitsa of the tab. of 8 mg No. 50

5 Rating 1 Reviews

Quality
Speed
Delivery
Performance
Price

Bromhexin-Darnitsa of the tab. of 8 mg No. 50

  • Product Code: 178715
  • In Stock

  • Ready to ship
  • $15.87


Related Products

Last Viewed

Модули для Opencart